Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common shares
Bitget2026/09/24 22:00- Elizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares on Sep. 22, 2026.
- The change followed option exercise of 5,070 shares at USD 1.12, then sales totaling 10,143 shares at USD 191.8521-USD 195.15.
- Derivative holdings fell to 1,095 stock options exercisable at USD 1.12, expiring Apr. 19, 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Jefferies lowers target price for Antero Resources
Euro-area Inflation: Headline pressures rise – Nordea
Broadcom and Blackstone jointly raise $60 billions to pave the way for AI compute power for companies such as Anthropic
Broadcom is leading a $60 billion debt financing initiative to provide funding for AI companies such as Anthropic to purchase chips and build data centers. Of this amount, $42 billion in senior secured bonds will be syndicated by Broadcom with Wall Street banks, while $18 billion in subordinated debt is being led by Blackstone, whose funds have committed $9 billion. The deal has been in preparation for several weeks but has not yet been officially announced.
Crypto prices
More
